Background: Breast carcinoma with fibrotic focus (FF) is significantly correlated with metastasis, targeted therapy resistance and
a poor prognosis of breast carcinoma. However, no reports
investigated the intratumor transcriptomic heterogeneity between fibrotic lesions and HER2 expression in breast cancer. This
study aimed to investigate transcriptomic features in different
HER2 expression levels and fibrosis grade of HR Negative Breast
Cancer.
第一作者机构：[1]Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
推荐引用方式(GB/T 7714)：
Yue Meng,Zhao Jianing,Wu Si,et al.Transcriptomic Profiling Reveals Molecular and Fibrotic Focus Hallmarks in Different HER2 Expression Levels of HR Negative Breast Cancer[J].LABORATORY INVESTIGATION.2025,105(3):doi:10.1016/j.labinv.2024.102492.
APA：
Yue, Meng,Zhao, Jianing,Wu, Si,Liu, Xudi,Wang, Yongjun&Liu, Yueping.(2025).Transcriptomic Profiling Reveals Molecular and Fibrotic Focus Hallmarks in Different HER2 Expression Levels of HR Negative Breast Cancer.LABORATORY INVESTIGATION,105,(3)
MLA：
Yue, Meng,et al."Transcriptomic Profiling Reveals Molecular and Fibrotic Focus Hallmarks in Different HER2 Expression Levels of HR Negative Breast Cancer".LABORATORY INVESTIGATION 105..3(2025)
